Cash Flow Statement

Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization EBIAT Long-Term Debt Issuances Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Preferred Shares Issued Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)R&D In Process Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding Wages, Salaries and Other

Ratios

Traws Pharma (TRAW) Shares Issued (2016 - 2025)

Traws Pharma (TRAW) has disclosed Shares Issued for 13 consecutive years, with $2.1 million as the latest value for Q4 2025.

For Q4 2025, Shares Issued changed N/A year-over-year to $2.1 million; the TTM value through Dec 2025 reached $5.6 million, up 458.2%, while the annual FY2025 figure was $5.6 million, 60.13% down from the prior year.
Shares Issued hit $2.1 million in Q4 2025 for Traws Pharma, up from $116000.0 in the prior quarter.
Across five years, Shares Issued topped out at $3.3 million in Q2 2025 and bottomed at $116000.0 in Q3 2025.
Average Shares Issued over 4 years is $771769.2, with a median of $500000.0 recorded in 2021.
On a YoY basis, Shares Issued climbed as much as 69.42% in 2021 and fell as far as 91.6% in 2021.
Traws Pharma's Shares Issued stood at $471000.0 in 2021, then increased by 6.16% to $500000.0 in 2022, then changed by 0.0% to $500000.0 in 2023, then skyrocketed by 317.4% to $2.1 million in 2025.
According to Business Quant data, Shares Issued over the past three periods came in at $2.1 million, $116000.0, and $3.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.